LYCOS RETRIEVER 
Cyclobenzaprine: Drugs
built 617 days ago
Cyclobenzaprine may not be suitable for all individuals. If you have had any of the following conditions in the past, or are being treated for them now, please inform your Health Care Provider. In some cases side effects may be minimized by following your Health Care Provider's advice, but you may be advised not to take Cyclobenzaprine. Before taking this drug, tell your Health Care Provider if you have: glaucoma, an overactive thyroid gland, heart disease, difficulty urinating or any allergies. Inform your Health Care Provider if you are pregnant or breast-feeding before taking this drug.
Source:
Pharmacologic similarities among the tricyclic drugs require that certain withdrawal symptoms be considered when Cyclobenzaprine HCl tablets are administered, even though they have not been reported to occur with this drug. Abrupt cessation of treatment after prolonged administration rarely may produce nausea, headache, and malaise. These are not indicative of addiction.
Source:
Cyclobenzaprine may interact with antidepressants of both the monoamine oxidase inhibitor class (MAOI's) and tricyclic antidepressants such as amitriptyline and imipramine. If taken with those drugs, a sudden increase in fever with convulsions may occur.
Source:
These patients are generally more susceptible to drugs with potentially sedating effects, including Cyclobenzaprine. Cyclobenzaprine HCl should be used with caution in subjects with mild hepatic impairment starting with a 5 mg dose and titrating slowly upward. Due to the lack of data in subjects with more severe hepatic insufficiency, the use of Cyclobenzaprine HCl in subjects with moderate to severe impairment is not recommended.
Source:
MORE ABOUT
Drugs